September 18, 2012 Joe Bormel
blog
Achieving MU Stage 2 is a complex undertaking that requires, among other things, the proper and efficient application of scalability. We need the ability to scale up what we did to achieve MU Stage 1. However, not all methods are scalable. So as we move forward to MU Stage 2, I’d like to make some recommendations for those of you who are resilient, but who really don’t like surprises.
September 13, 2012 Jennifer Prestigiacomo
article
Stage 2 meaningful use calls for encryption of data on end-user devices. With many clinicians, especially physicians, increasingly bringing their own BlackBerrys, iPhones, iPads, Android devices, and other handhelds, into patient care organizations for their personal clinical use, what some term the bring your own device (BYOD) movement, IT leaders could be faced with a challenging situation when it comes to securing these devices.
August 30, 2012 Gabriel Perna and Mark Hagland
article
When it comes to the aftermath of the meaningful use Stage 2 final rule, released recently by the federal Centers for Medicare and Medicaid (CMS), EHR vendors find themselves relieved, but still very much under the gun. Even with the delay to the start of attestation, these EHR vendors, with large client bases, are acknowledging that time is of the essence.
August 30, 2012
news
According to a recent report from KLAS Research, an Orem, Utah research firm, most providers have not attested for meaningful use Stage 1, citing quality measures and reporting as their biggest challenges. This has led them to increasingly reach out to consultants for assistance, says the KLAS report, Rapid Growth of Meaningful Use Consulting: Why Providers Are Reaching Out.
August 29, 2012 Mark Hagland
blog
What's most fascinating about the final rule for Stage 2 of meaningful use is not what was surprising, but what wasn't surprising. Then again, the leaders of the pioneering patient care organizations in this country already understand the direction of the new healthcare; for them, meaningful use is just one (very big) element in the overall operational landscape.
August 29, 2012 Joe Marion
blog
I have been reading several posts attempting to interpret the impact of the final ruling for ARRA/MU Stage 2, and the absence of imaging. As best I can conclude, the “image” of imaging is one of total confusion!
August 29, 2012 Gabriel Perna
blog
After the CMS released the proposed rule for Stage 2 of meaningful use, it received a ton of pushback from providers on the patient engagement requirement, which asked for 10 percent of patients look at their data, download it, or transmit it to others through a portal. While it lowered the threshold by five percent, the point has been reinforced. Whether you like the patient engagement requirement or not, it’s time to push forward.
August 28, 2012 Jeff Smith, Assistant Director of Advocacy at CHIME
article
Christmas came August 23rd this year for those of us health IT policy wonks. And our presents were so complex we were still trying to figure out how to make it work the next day. I am, of course, talking about Meaningful Use Stage 2 (also trending on Twitter as #MUS2). Stage 2 final regulations were issued by CMS and ONC this Thursday at 2:30pm ET and CHIME Advocacy HQ has been in a frenzy since.
August 28, 2012 Gabriel Perna
article
Across the industry, the responses to CMS’ Stage 2 Final Rule are coming into focus. The changes from the proposed rule to the final rule represent a compromise, lessening the burden on providers while establishing a clear path forward.
August 28, 2012 Jennifer Prestigiacomo and David Raths
article
Many in the industry are mostly positive about the changes that were made in the final rule of meaningful use Stage 2, which the federal Centers for Medicare & Medicaid Services (CMS) issued last Thursday, Aug. 23. As HCI Senior Contributing Editor David Raths detailed in his Aug. 24 blog, there have been several key changes and innovations in the final rule. To illustrate these images, HCI has put together a pictorial view of the major changes seen in the final rule.
August 27, 2012 Jennifer Prestigiacomo and Mark Hagland
article
Industry reaction has been largely positive toward the final rule for Stage 2 meaningful use, but many acknowledge that even though there is relief in the timeline, many requirements will still be challenging to meet. Clinical quality measure reporting still remains daunting for many providers.
August 27, 2012 Jennifer Prestigiacomo
article
In this podcast, Robin Raiford, research director in the Advisory Board’s IT Strategy Council, will be sharing her analysis and key takeaways from the Stage 2 meaningful use final rule. Raiford is a clinical informatics and meaningful use expert and industry speaker. She also specializes in clinical decision support and computerized provider order entry (CPOE). Raiford is the creator of the Meaningful Use Stage 1 Final Rule, The White Board Story which is a summary view of all the regulatory documents surrounding meaningful use and the EHR incentive program.
_0_33.jpg)
